Results 121 to 130 of about 7,378 (198)

Impact of Oral Mesalamine on Clinical Remission and Mucosal Response in Mild to Moderate Ulcerative Colitis: A Prospective Observational Study. [PDF]

Cureus
Nabeel L, Khurshid M, Amjad A, Abbas Raja A, Ishtiaq H, Hussain S, Umer MR, Jan HA, Khattak MI, Masood S.   +9 more
europepmc   +1 more source

A Case with a Pathological Course Resembling Ulcerative Colitis after Rectal Cancer Surgery with Diversion. [PDF]

Surg Case Rep
Shimizu T, Kitazawa M, Hirayama A, Nakamura S, Yamamoto Y, Miyazaki S, Hondo N, Kataoka M, Tanaka H, Kuroiwa M, Ishizaka N, Yamamoto N, Soejima Y.   +12 more
europepmc   +1 more source

A comprehensive review of usefulness of sodium butyrate for the management of inflammatory bowel disease: from molecular mechanisms to clinical application. [PDF]

Prz Gastroenterol
Karłowicz K, Lewandowski K, Tulewicz-Marti E, Rydzewska G.   +3 more
europepmc   +1 more source

Cap Polyposis Mimicking Rectal Neoplasia in an Adolescent. [PDF]

United European Gastroenterol J
Huang M, Wu J.
europepmc   +1 more source

Defined Natural Products as Adjunctive Therapies: Evidence-Gated Polypharmacology Across Molecular Targets, Human Exposure, Clinical Signals, and Safety Boundaries. [PDF]

Int J Mol Sci
Seo Y, Woo J.
europepmc   +1 more source

Back to the Future: Repurposing Metformin, a Metabolically Active Drug, to Treat Mild-to-Moderate Ulcerative Colitis. [PDF]

Metabolites
Antonelli E, Dell'Era A, Maconi G, Bassotti G.   +3 more
europepmc   +1 more source

Mesalamine as a Suspected Cause of Drug-Induced Pancreatitis: A Case Report and Review of Diagnostic Considerations. [PDF]

Cureus
Arellano Villanueva E, Lopez M, Asaad A, Campo Maldonado JE.   +3 more
europepmc   +1 more source

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocol. [PDF]

BMJ Open
Backman AS, Frank A, Lindberg LJ, Ljungman D, Silander G, Gustafsson RJ, Bozsó T, Schmidt PT, Ingre M, Mittlbock M, Löwbeer C, Marsal J, Lindblom A, Tham E, Therkildsen C, Gasche C, International MesaCAPP Study Group.   +16 more
europepmc   +1 more source

The Use and Role of Mesalamine in the Treatment of Ulcerative Colitis: A Literature Review. [PDF]

Cureus
Chand S, Bendagiri Matam M, Bhatt NK, Neelakantan Ramaswamy S, Harikrishnan S, Agarwal Y, Mohammed L.   +6 more
europepmc   +1 more source

Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey". [PDF]

Intest Res
Limsrivilai J, Leung WK.
europepmc   +1 more source